Hunan Arshine Pharmaceutical Co., Limited – Trademark Portfolio
Entity Type: 99
Hunan Arshine Pharmaceutical Co., Limited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ARSHINE.
5th floor, Building 14, Xinggong International Park,
No. 100, Luyun Road 410205 Changsha
Showing of trademarks Trademarks
Trademark Classifications
Hunan Arshine Pharmaceutical Co., Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Hunan Arshine Pharmaceutical Co., Limited have?
Hunan Arshine Pharmaceutical Co., Limited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hunan Arshine Pharmaceutical Co., Limited file in?
Hunan Arshine Pharmaceutical Co., Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Hunan Arshine Pharmaceutical Co., Limited's most well-known trademarks?
Hunan Arshine Pharmaceutical Co., Limited's registered trademark portfolio includes well-known marks such as ARSHINE. These are among 1 currently registered trademark in the portfolio.
What is Hunan Arshine Pharmaceutical Co., Limited's trademark registration success rate?
Hunan Arshine Pharmaceutical Co., Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.